SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-24-000688
Filing Date
2024-01-05
Accepted
2024-01-05 17:15:14
Documents
9
Period of Report
2024-01-05

Document Format Files

Seq Description Document Type Size
1 PRE 14A a20240105pre-14a.htm PRE 14A 372604
2 computera.jpg GRAPHIC 3083
3 frtx_logoxcolora.jpg GRAPHIC 64155
4 mla.jpg GRAPHIC 3585
5 proxy1aa.jpg GRAPHIC 239799
6 proxy1ba.jpg GRAPHIC 335398
7 proxy2aa.jpg GRAPHIC 113019
8 proxy2ba.jpg GRAPHIC 909065
9 tela.jpg GRAPHIC 3575
  Complete submission text file 0001628280-24-000688.txt   2670980
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-21088 | Film No.: 24517505
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)